Oaktop Capital Management II’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Hold |
479,991
| – | – | 2.39% | 7 |
|
|
2025
Q1 | $29.3M | Hold |
479,991
| – | – | 3.9% | 5 |
|
|
2024
Q4 | $27.1M | Hold |
479,991
| – | – | 3.39% | 7 |
|
|
2024
Q3 | $24.8M | Sell |
479,991
-200,000
| -29% | -$10.3M | 2.71% | 7 |
|
|
2024
Q2 | $28.2M | Hold |
679,991
| – | – | 2.89% | 6 |
|
|
2024
Q1 | $36.9M | Hold |
679,991
| – | – | 4.26% | 6 |
|
|
2023
Q4 | $34.9M | Hold |
679,991
| – | – | 4.63% | 6 |
|
|
2023
Q3 | $39.5M | Hold |
679,991
| – | – | 6.59% | 4 |
|
|
2023
Q2 | $43.5M | Hold |
679,991
| – | – | 6.61% | 4 |
|
|
2023
Q1 | $47.1M | Hold |
679,991
| – | – | 7.92% | 4 |
|
|
2022
Q4 | $48.9M | Hold |
679,991
| – | – | 8.76% | 4 |
|
|
2022
Q3 | $48.3M | Hold |
679,991
| – | – | 9.72% | 4 |
|
|
2022
Q2 | $52.4M | Hold |
679,991
| – | – | 9.48% | 4 |
|
|
2022
Q1 | $49.7M | Hold |
679,991
| – | – | 7.09% | 5 |
|
|
2021
Q4 | $42.4M | Hold |
679,991
| – | – | 5.11% | 5 |
|
|
2021
Q3 | $40.2M | Hold |
679,991
| – | – | 5.57% | 5 |
|
|
2021
Q2 | $45.4M | Hold |
679,991
| – | – | 6.5% | 5 |
|
|
2021
Q1 | $42.9M | Hold |
679,991
| – | – | 6.62% | 5 |
|
|
2020
Q4 | $42.2M | Hold |
679,991
| – | – | 7.43% | 5 |
|
|
2020
Q3 | $41M | Hold |
679,991
| – | – | 9.06% | 4 |
|
|
2020
Q2 | $40M | Hold |
679,991
| – | – | 9.4% | 4 |
|
|
2020
Q1 | $37.9M | Buy |
679,991
+125,000
| +23% | +$6.97M | 11.6% | 3 |
|
|
2019
Q4 | $35.6M | Buy |
+554,991
| New | +$35.6M | 9.35% | 4 |
|